TONYA KRIEG: Open Payments
NPI 1598350910 · PRINCETON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$976 in 60 payments from 17 companies in 2025. Trend: 2023 $724 · 2024 $928 · 2025 $976
Food & beverage: $976
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $262 |
| AstraZeneca Pharmaceuticals LP | 6 | $142 |
| Axsome Therapeutics, Inc. | 8 | $141 |
| Lilly USA, LLC | 4 | $68 |
| PFIZER INC. | 3 | $51 |
| Amgen Inc. | 3 | $50 |
| Novo Nordisk Inc | 3 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Lundbeck LLC | 2 | $34 |
| Insulet Corporation | 1 | $26 |
Products named: Auvelity, FARXIGA, QULIPTA, UBRELVY, REXULTI, JARDIANCE, OTEZLA, VRAYLAR.
Industry payments across IN — which companies pay providers there.
